420 related articles for article (PubMed ID: 22672151)
1. A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer.
Kyrdalen AE; Dahl AA; Hernes E; Småstuen MC; Fosså SD
BJU Int; 2013 Feb; 111(2):221-32. PubMed ID: 22672151
[TBL] [Abstract][Full Text] [Related]
2. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy.
Lilleby W; Fosså SD; Waehre HR; Olsen DR
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):735-43. PubMed ID: 10098428
[TBL] [Abstract][Full Text] [Related]
3. Population-based study of long-term functional outcomes after prostate cancer treatment.
Carlsson S; Drevin L; Loeb S; Widmark A; Lissbrant IF; Robinson D; Johansson E; Stattin P; Fransson P
BJU Int; 2016 Jun; 117(6B):E36-45. PubMed ID: 25959859
[TBL] [Abstract][Full Text] [Related]
4. Prospective assessment of voiding and sexual function after treatment for localized prostate carcinoma: comparison of radical prostatectomy to hormonobrachytherapy with and without external beam radiotherapy.
Fulmer BR; Bissonette EA; Petroni GR; Theodorescu D
Cancer; 2001 Jun; 91(11):2046-55. PubMed ID: 11391584
[TBL] [Abstract][Full Text] [Related]
5. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
[TBL] [Abstract][Full Text] [Related]
6. Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.
Barocas DA; Alvarez J; Resnick MJ; Koyama T; Hoffman KE; Tyson MD; Conwill R; McCollum D; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Penson DF
JAMA; 2017 Mar; 317(11):1126-1140. PubMed ID: 28324093
[TBL] [Abstract][Full Text] [Related]
7. Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.
Hoffman KE; Penson DF; Zhao Z; Huang LC; Conwill R; Laviana AA; Joyce DD; Luckenbaugh AN; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Koyama T; Barocas DA
JAMA; 2020 Jan; 323(2):149-163. PubMed ID: 31935027
[TBL] [Abstract][Full Text] [Related]
8. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
[TBL] [Abstract][Full Text] [Related]
9. Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.
Hedgepeth RC; Labo J; Zhang L; Wood DP
J Urol; 2009 Jul; 182(1):221-7; discussion 227-8. PubMed ID: 19450842
[TBL] [Abstract][Full Text] [Related]
10. Reduction of quality of life in prostate cancer patients: experience among 6200 men in the Nordic countries.
Fosså SD; Bengtsson T; Borre M; Ahlgren G; Rannikko A; Dahl AA
Scand J Urol; 2016 Oct; 50(5):330-7. PubMed ID: 27398736
[TBL] [Abstract][Full Text] [Related]
11. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
Bradley EB; Bissonette EA; Theodorescu D
BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117
[TBL] [Abstract][Full Text] [Related]
12. Long-term quality of life among localised prostate cancer survivors: QALIPRO population-based study.
Kerleau C; Guizard AV; Daubisse-Marliac L; Heutte N; Mercier M; Grosclaude P; Joly F;
Eur J Cancer; 2016 Aug; 63():143-53. PubMed ID: 27318002
[TBL] [Abstract][Full Text] [Related]
13. Quality of life after radical prostatectomy or watchful waiting.
Steineck G; Helgesen F; Adolfsson J; Dickman PW; Johansson JE; Norlén BJ; Holmberg L;
N Engl J Med; 2002 Sep; 347(11):790-6. PubMed ID: 12226149
[TBL] [Abstract][Full Text] [Related]
14. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.
Potosky AL; Legler J; Albertsen PC; Stanford JL; Gilliland FD; Hamilton AS; Eley JW; Stephenson RA; Harlan LC
J Natl Cancer Inst; 2000 Oct; 92(19):1582-92. PubMed ID: 11018094
[TBL] [Abstract][Full Text] [Related]
15. Sexual function with localized prostate cancer: active surveillance vs radical therapy.
van den Bergh RC; Korfage IJ; Roobol MJ; Bangma CH; de Koning HJ; Steyerberg EW; Essink-Bot ML
BJU Int; 2012 Oct; 110(7):1032-9. PubMed ID: 22260273
[TBL] [Abstract][Full Text] [Related]
16. Prostate operations: long-term effects on sexual and urinary function and quality of life. Comparison with an age-matched control population.
Deliveliotis C; Liakouras C; Delis A; Skolarikos A; Varkarakis J; Protogerou V
Urol Res; 2004 Aug; 32(4):283-9. PubMed ID: 15057494
[TBL] [Abstract][Full Text] [Related]
17. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with prostate cancer - EORTC QLQ-PR25.
Park J; Shin DW; Yun SJ; Park SW; Jeon SS; Kwak C; Kwon TG; Kim HJ; Ahn H
Oncology; 2013; 85(5):299-305. PubMed ID: 24217330
[TBL] [Abstract][Full Text] [Related]
18. Bother problems in prostate cancer patients after curative treatment.
Stensvold A; Dahl AA; Brennhovd B; Småstuen MC; Fosså SD; Lilleby W; Steinsvik A; Axcrona K; Smeland S
Urol Oncol; 2013 Oct; 31(7):1067-78. PubMed ID: 22341412
[TBL] [Abstract][Full Text] [Related]
19. Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal Therapy.
Adam M; Tennstedt P; Lanwehr D; Tilki D; Steuber T; Beyer B; Thederan I; Heinzer H; Haese A; Salomon G; Budäus L; Michl U; Pehrke D; Stattin P; Bernard J; Klaus B; Pompe RS; Petersen C; Huland H; Graefen M; Schwarz R; Huber W; Loeb S; Schlomm T
Eur Urol; 2017 Mar; 71(3):330-336. PubMed ID: 27887941
[TBL] [Abstract][Full Text] [Related]
20. Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study.
Mazariego CG; Egger S; King MT; Juraskova I; Woo H; Berry M; Armstrong BK; Smith DP
BMJ; 2020 Oct; 371():m3503. PubMed ID: 33028540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
